Myriad Genetics and Flatiron Health have formed a strategic partnership to make genetic testing more accessible.
will integrate Myriad's MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform, allowing healthcare providers to easily order and review test results within their existing workflows.
The goal is to streamline the process and enhance the usability of germline testing, ultimately leading to more personalized treatment decisions for patients.
is expected to improve patient outcomes by providing critical health information at the point of care and empowering clinicians to make informed decisions.
The partnership also reflects the broader trend in the healthcare industry towards integrating technology and data-driven solutions.